A population-based longitudinal study of cognitive functioning in the menopausal transition

Neurology

Volumn 61, Issue 6, 2003, Pages 801-806

  Meyer, Peter M ^a,b   Powell, L H ^a   Wilson, R S ^a   Everson Rose, S A ^a   Kravitz, H M ^a   Luborsky, J L ^a   Madden, T ^a   Pandey, D ^a   Evans, D A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Preventive Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGING; ARTICLE; CAUCASIAN; CLIMACTERIUM; COGNITION; CONTROLLED STUDY; DIAGNOSTIC TEST; EDUCATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INCOME; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; NEGRO; PERCEPTION; POPULATION RESEARCH; PREMENOPAUSE; PRIORITY JOURNAL; SELF CONCEPT; SYMBOL DIGIT MODALITIES TEST; UNITED STATES; WORKING MEMORY;

EID: 0141542561     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000079051.91602.E2     Document Type: Article

References (34)

1. Matthews KA, Wing RR, Kuller LH, et al. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 1994;154:2349-2355.
2. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473.
3. Jones KP. Menopause and cognitive function: estrogens and alternative therapies. Clin Obstet Gynecol 2000;43:198-206.
4. Mitchell ES, Woods NF. Midlife women's attributions about perceived memory changes. Observations from the Seattle Midlife Women's Health Study. J Women Health Gen-B 2001;10:351-362.
5. Gordon HW, Lee PA. No difference in cognitive performance between phases of the menstrual cycle. Psycheneuroendocrinology 1993;18:521-531.
6. Hampson E, Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav Neurosci 1988;102:456-459.
7. Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87(suppl):20S-26S.
8. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology 1990;15:97-111.
9. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.
10. Farmer ME, White LR, Kittner SJ, et al. Neuropsychological test performance in Framingham: a descriptive study. Psychol Rep 1987;60(3 Pt 2):1023-1040.
11. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
12. Sowers M, Crawford S, Sternfeld B, et al. SWAN: A multi-center, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, eds. Menopause: biology and pathobiology. San Diego: Academic Press, 2000;175-188.
13. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol 2003;60:185-189.
14. Wechsler D. Wechsler Memory Scale-Revised manual. New York: The Psychological Corporation, 1987.
15. Smith A. Symbol Digit Modalities Test manual-revised. Los Angeles: Western Psychological Services, 1982.
16. World Health Organization. Research on the menopause in the 1990s. WHO Technical Report Series. Report No 866. Geneva: World Health Organization, 1996.
17. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-878.
18. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
19. Matthews KA, Cauley J, Yaffe K, et al. ERT and cognitive decline. J Am Geriatr Soc 2000;48:346.
20. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-974.
21. Barnard J, Rubin DB. Small-sample degrees of freedom with multiple imputation. Biometrika 1999;86:948-955.
22. Insightful. S-Plus 6 for Windows guide to statistics, volume 1. Seattle: Insightful Corporation, 2001.
23. Horton AM, Jr. Neuropsychological practice effects x age: a brief note. Percept Mot Skills 1992;75:257-258.
24. McCaffrey RJ, Westervelt HJ. Issues associated with repeated neuropsychological assessments. Neuropsychol Rev 1995;5:203-221.
25. Mitrushina M, Satz P. Effect of repeated administration of a neuropsychological battery in the elderly. J Clin Psychol 1991;47:790-801.
26. Haskell SG, Richardson ED, Horwitz RI. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 1997;50:1249-1264.
27. LeBlanc ES, Janowsky J, Chan BK, et al. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001;285:1489-1499.
28. Chiarello C, McMahon MA, Schaefer K. Visual cerebral lateralization over phases of the menstrual cycle: a preliminary investigation. Brain Cogn 1989;11:18-36.
29. Newton C, Slota D, Yuzpe AA, et al. Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertil Steril 1996;65:1253-1255.
30. Sherwin BB, Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 1996;81:2545-2549.
31. Owens JF, Matthews KA, Everson SA. Cognitive function effects of suppressing ovarian hormones in young women. Menopause 2002;9:227-235.
32. Albert M, Smith LA, Scherr PA, et al. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
33. Yaffe K, Barnes D, Nevitt M, et al. A prospective study of physical activity and cognitive decline in elderly women: women who walk, Arch Intern Med 2001;161:1703-1708.
34. Yaffe K, Lui LY, Grady D, et al. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 2000;356:708-712.